
GKB Ophthalmics Stock Falls to 52-Week Low of Rs.53 Amidst Continued Underperformance
2025-12-03 10:20:13GKB Ophthalmics has reached a new 52-week low of Rs.53, marking a significant decline in its stock price over the past year. This level reflects ongoing challenges faced by the company within the healthcare services sector, as it continues to trade below key moving averages and underperform relative to broader market indices.
Read More
GKB Ophthalmics Stock Falls to 52-Week Low of Rs.54 Amidst Continued Downtrend
2025-12-02 12:42:53GKB Ophthalmics has reached a new 52-week low of Rs.54 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the healthcare services segment.
Read More
GKB Ophthalmics Falls to 52-Week Low of Rs.56 Amidst Prolonged Downtrend
2025-11-24 10:32:54GKB Ophthalmics has reached a new 52-week low of Rs.56 today, marking a significant milestone in its ongoing price decline. This level reflects a continuation of the stock’s subdued performance over the past year, contrasting sharply with broader market gains.
Read More
GKB Ophthalmics Stock Falls to 52-Week Low of Rs.56 Amidst Continued Underperformance
2025-11-24 10:32:53GKB Ophthalmics touched a fresh 52-week low of Rs.56 today, marking a significant decline in its share price over the past year. The stock’s performance contrasts sharply with broader market gains, reflecting ongoing challenges within the company’s financial metrics and valuation.
Read More
GKB Ophthalmics Stock Falls to 52-Week Low of Rs.56 Amidst Continued Underperformance
2025-11-24 10:32:48GKB Ophthalmics has reached a new 52-week low of Rs.56, marking a significant decline in its stock price amid ongoing challenges in financial performance and market positioning within the healthcare services sector.
Read More
GKB Ophthalmics Stock Falls to 52-Week Low of Rs.56 Amidst Continued Underperformance
2025-11-24 10:32:41GKB Ophthalmics has reached a new 52-week low of Rs.56, marking a significant decline in its stock price as it continues to lag behind key market benchmarks and sector averages.
Read MoreWhy is GKB Ophthalmics falling/rising?
2025-11-22 00:47:34Persistent Underperformance Against Benchmarks GKB Ophthalmics has been struggling to keep pace with the broader market, as evidenced by its returns relative to the Sensex. Over the past week, the stock declined by 4.20%, while the Sensex gained 0.79%. This divergence has only widened over longer periods, with the stock falling 12.34% in the last month compared to a 0.95% rise in the Sensex. Year-to-date figures reveal a stark contrast: GKB Ophthalmics has plummeted 41.37%, whereas the Sensex has advanced by 9.08%. The one-year and three-year comparisons further highlight the stock’s persistent weakness, with losses exceeding 40% against Sensex gains of over 10% and 39%, respectively. Even over five years, the stock’s modest 9.45% gain pales in comparison to the Sensex’s robu...
Read More
GKB Ophthalmics Falls to 52-Week Low of Rs.57.6 Amidst Continued Downtrend
2025-11-21 11:18:09GKB Ophthalmics has reached a new 52-week low of Rs.57.6, marking a significant decline as the stock continues its downward trajectory amid broader market stability.
Read More
GKB Ophthalmics Falls to 52-Week Low of Rs.58.73 Amidst Continued Downtrend
2025-11-19 15:11:44GKB Ophthalmics has reached a new 52-week low of Rs.58.73 today, marking a significant point in its recent price trajectory. The stock has experienced a sustained decline over the past five trading sessions, culminating in a cumulative return loss of 7.61% during this period.
Read MoreBoard Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.
30-Jan-2026 | Source : BSEGKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Inside Trading Window) Regulations 2015 had been closed from January 01 2026 will now re-open after the completion of 48 hours from the date of submission of Financial results to the Stock Exchange. This communication has been sent to all the Directors and all the designated employees of the Company.
Intimation On Conversion Of Statutory Auditors Firm Into LLP- MSKA & Associates To MSKA & Associates LLP Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015.
20-Jan-2026 | Source : BSEWe would like to inform you that the Statutory Auditors of the Company MSKA & Associates Chartered Accountants have intimated the Company that the Firm has converted itself into a Limited Liability Partnership (LLP) under the provision of the Limited Liability Partnership Act 2008 and is now known as MKS & Associates LLP Chartered Accountants. The will continue to function and discharge their obligations as Auditors for the remaining period of the tenure of appointment as statutory Auditors. This is for your information an records.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08-Jan-2026 | Source : BSEPlease find herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended December 31 2025. Kindly acknowledge receipt of the same.
Corporate Actions
No Upcoming Board Meetings
GKB Ophthalmics Ltd has declared 12% dividend, ex-date: 21 Sep 10
No Splits history available
No Bonus history available
No Rights history available